and reperfusion, there were no differences in hemodynamic parameters or RMBF among three groups.
74± 9%* 18 ± 6%* 6.6 ± 0.1' 91 ±90/0'" 126 ± 7%· 32 ± 16% fied by measurement of augmentation index as having either a normal early systolic peak (Type C) or abnormal late systolic peak (Type A-indicating early wave reflection). Compared to N, the treated hypertensives had significantly higher LVMI (98 ± 22 vs 82 ± 22 g/m 2 , p < 0.05) and carotid IMT (0.74 ± 0.17 vs 0.61 ± 0.15, P < 0.05). There were no significant differences in LVwall thickness, relative wall thickness or LV mass index between subjects with Type A and Type C arterial waveforms. In contrast, carotid IMT was significantly increased in patients with Type A arterial waveforms. 
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One of the most serious complications of systemic hypertension is myocardial tissue damage, including left ventricular hypertrophy, as a consequence of increased protein synthesis. However, the modulating role of translational events in the hypertrophy-regression transition is poorly understood, especially where therapeutic regimes have been employed. These events were investigated in vivo in a genetic model of hypertension, namely in the spontaneously hypertensive rat (SHR); comparative responses were investigated in normotensive Wistar Kyoto rats (WKY). Rats were used at 4 months of age and treated with either the ACE-inhibitor lisinopril (5 mglkg/day) in tap water or plain tap water (controls). The groups were assigned as follows: WKY-CON, normotensive controls; WKY-L1S, normotensives plus lisinopril; SHR-CON, hypertensive controls; SHR-L1S, hypertensives plus lisinopril. Fractional rates of protein synthesis (ks defined as the percentage of the myofibrillary protein pool renewed each day; %/day) were measured in vivo with the flooding dose technique using L-[4-3 H]phenylalanine. Left ventricular myofibrillary proteins were extracted by differential solubility and high-speed centrifugation techniques; purity was assessed with SDS-PAGE. After 8 weeks treatment the myofibrillary protein contents (mg per region) in normotensive rats were as follows (all data as mean ± SEMS, n = 6-9): WKY-CON, 45 ± 1 mg; WKY-L1S, 36 ± 1 (p < 0.001). In the hypertensive group regression of contractile protein content occurred; i.e., SHR-CON, 52 ± 3 mg; SHR-L1S, 38 ± 
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Hypertensive patients who develop left ventricular hypertrophy (LVH) are at much greater cardiovascular risk than those without and in particular their incidence of sudden death is several times higher. This may be mediated by an increase in ventricular arrhythmias. It has recently been suggested that aT dispersion may indicate arrhythmia risk by reflecting dispersion of recovery of ventricular excitability.
In order to test the hypothesis that left ventricular hypertrophy may be associated with an increase in aT dispersion 100 previously untreated subjects were studied. These consisted of 52 subjects with essential hypertension (BP > 160/90). 21 subjects with borderline hypertension (BP > 140/85) and 27 normotensives. Each underwent 2 dimensional and Doppler echocardiography to determine left ventricular mass index (LVMI), E/A ratio and isovolumic relaxation time (IVRT). Additionally from a 12-lead ECG examination aT length was measured for each lead and corrected for heart rate (OTc). OTc dispersion was determined as the difference between the maximum and minimum OTc interval.
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RV-LVI In the DCM hearts mean (±SD) LV-RVI gain was 0.26 ± 0.06 and RV-LVI was 0.16 ± 0.12.ln the control heart LV-RVI = 0.08 and RV-LVI = 0.15. LV-RVI is markedly increased in heart failure when compared to the control. This is consistent with previous reports using animal models. Conversely, RV-LVI remains unaffected by heart failure. These data, not previously available from humans, suggest that LV contribution to RV performance is significantly enhanced in chronic heart failure.
Left ventricular (LV) contraction contributes importantly to right ventricular (RV) performance via left to right ventricular interaction (LV-RVI). To determine the magnitude of LV-RVI in human heart failure, 5 explanted hearts with dilated cardiomyopathy (DCM) were obtained at the time of transplant and restored to a beating condition using a blood perfusion system. One normal human heart, unsuitable for transplantation, was also obtained and served as control. Balloons were placed in both RV and LV With RV volume fixed at an end diastolic pressure ( 
